IRIS-Onyx Cohort in the IRIS-DES Registry

Seung-Jung Park

Status: Active, not recruiting

Conditions: Coronary Artery Disease; Arterial Occlusive Diseases; Cardiovascular Diseases; Percutaneous Transluminal Angioplasty

Treatments: Device: Onyx Drug Eluting Stent group

Study type: Observational

Funder types: Other

Identifiers

NCT02593994

AMCCV2015-04

Details and patient eligibility

About

The purpose of this study is to evaluate the relative effectiveness and safety of Onyx stent compared to other (drug eluting stents) DES.

Enrollment: 4,500 patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 19 and more
• Intervention with Onyx Drug Eluting Stent
• Agreed with written informed consent form

Exclusion criteria

• Intervention with Onyx drug eluting coronary stent and other drug eluting stent at the same time
• Life expectancy of 1year and under
• Cardiac shock

Trial design

4,500 participants in 1 patient group

Onyx Drug Eluting Stent

Treatment:

Device: Onyx Drug Eluting Stent group